2012 Jiva April Cover 220 GSM Art Card Glossy ... - Jivaonline.net

GENERAL ARTICLEJ. Ind. Vet. Assoc., Kerala. 10 (1)Barbe, J. and Pages, J.M. 2006. Quinolinederivatives as promising inhibitors ofantibiotic efflux pump in multidrug resistantEnterobacter aerogenes isolates. CurrentDrug Targets, 7 (7): 843-847.Malléa, M., Chevalier, J., Eyraud, A. and Pagès, J.M.2002. Inhibitors of antibiotic efflux pumpinresistant Enterobacter aerogenes strains.Biochem. Biophys. Res. Comm., 293: 1370-1373.Marquez, B., Neuville, L., Moreau, N.J., Genet, J.P.,dos Santos, A.F., Caño de Andrade, M.C. andSant'Ana, A.E. 2005. Multidrug resistancereversal agent from Jatropha elliptica.Phytochemistry, 66(15):1804-11.Martins, M., Dastidar, S. G. and Fanning, S. 2008.Potential role of non-antibiotics (helpercompounds) in treatment of multidrugresistantgram-negative infections:mechanisms for their direct and indirectactivities. Int. J. Antimicrob. Agents., 31: 198-208.Mc Murry, L., R. E. Petrucci, Jr., and S. B. Levy.1980. Active efflux of tetracycline encoded byfour genetically different tetracyclineresistance determinants in Escherichia coli.Proc. Natl. Acad. Sci. U.S.A. 77: 3974-3977.Mullin,S., Mani, N. and Grossman, T. H. 2004.Inhibition of Antibiotic Efflux in Bacteria bythe Novel Multidrug Resistance InhibitorsBiricodar (VX-710) and Timcodar (VX-853).Antimicrob. Agents Chemother., 48(11): 4171-4176Nargotra, A., Sharma, S., Koul, J.L., Sangwan, P.L.,Khan, I.A., Kumar, A., Taneja, S.C. and Koul,S. 2009. Quantitative structure activityrelationships (QSAR) of piperine analogs forbacterial NorA efflux pump inhibitors. Eur. J.Med. Chem., 44(10): 4128-35Nelson, M.L. and Levy, S.B. 1999. Reversal oftetracycline resistance mediated by differentbacterial tetracycline resistance determinantsby an inhibitor of the Tet(B) antiport protein.Antimicrob. Agents Chemother., 43: 1719-1724.Neyfakh, A.A., Bidnenko, V.E. and Bo Chen, L.1991. Efflux-mediated multidrug resistancein Bacillus subtilis: similarities anddissimilarities with the mammalian system.Proc. Natl. Acad. Sci. USA., 88: 4781-4785Pagès, J.M., Dimarcq, J.L., Quenin, S. and Hetru, C.2003. Thanatin activity on multidrug resistantclinical isolates of Enterobacter aerogenesand Klebsiella pneumonia. Int. J. Antimicrob.Agents., 22: 265-269.Pages, J. M., Muriel Masi. and Jacques Barbe. 2005.Inhibitors of efflux pumps Gram-negativebacteria.Trends in Molecular Medicine,11(8):382-389.Piddock, L.V. 2006. Clinically relevantchromosomally encoded multi drug resistanceefflux pumps in bacteria. Clin. Microbiol.Rev.,19: 382-402.Poole, K. 2002. Mechanisms of bacterial biocide andantibiotic resistance. J. Appl.Microbiol.,92(suppl 1): 55-64Renau, T.E., Léger, R., Filonova, L., Flamme, E.M.,Wang, M., Yen, R., Madsen, D., Griffith, D.,Chamberland, S., Dudley, M.N., Lee, V.J.,Lomovskaya, O., Watkins, W.J., Ohta, T.,Nakayama, K. and Ishida, Y. 2003.Conformationally-restricted analogues ofefflux pump inhibitors that potentiate theactivity of levofloxacin in Pseudomonasaeruginosa. Bioorg. Med. Chem. Lett., 13:2755-2758.Roccaro, S.A., Blanco, A.R., Giuliano, F., Rusciano,D. and Enea, V. 2004. Epigallocaechingallateenhances the activity of tetracyclinesin staphylococci by inhibiting its efflux frombacterial cells. Antimicrob. AgentsChemother., 48: 1968-1973.Rothstein, D.M., McGlynn, M. and Bernan, V.74